Aoxing Pharmaceutical Company, Inc. Declines To Comment On Market Activity
JERSEY CITY, N.J., Sept. 13, 2012 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN). In view of the unusual activity today in the market for the common stock of Aoxing Pharmaceutical Company, Inc., the NYSE Euronext has contacted the company in accordance with the Exchange's usual practice. The company stated that its policy is not to comment on unusual market activity.
CONTACT:
Aoxing Pharmaceutical Company:
646-367-1747
investor.relations@aoxingpharma.com
SOURCE Aoxing Pharmaceutical Company, Inc.
More by this Source
Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
May 15, 2013, 16:21 ET
Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quarter Of 2013 Fiscal Year
Feb 15, 2013, 11:05 ET
Aoxing Pharmaceutical Company, Inc. Announces Receipt Of Production License For Pholcodine
Jan 28, 2013, 08:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.